Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 1 - 20 of 24
  • 1
  • 2
  • »
A deep dive into 4 topics discussed during a series of interactive sessions at the ACCC 49th Annual Meeting and Cancer Center Business Summit: business and artificial intelligence technology, research and clinical trials, and precision medicine.
Lankenau Medical Center operationalized this joint ASCO-ACCC implicit bias aimed at ensuring patients with cancer in underrepresented groups have equitable access to care and clinical trials.
Under ACORI, ACCC helps community oncology programs access the tools, knowledge sharing, effective practices, and peer mentorships that can increase their ability to offer clinical trials.
Learn the 10 feasible and impactful “how-tos” Summit participants identified within three domains—care coordination and communication, clinical trials, and acknowledging and mitigating implicit bias.
One of the ways in which community oncology is helping to close gaps in cancer research is through participation in the National Cancer Institute Community Oncology Research Program clinical trials. The Lahey Health Cancer Institute, a part of the Beth Israel Lahey Health System, continues to expand access to clinical trials and, in particular, the NCI National Clinical Trials Network into the community …
One important step toward supporting the health of Indigenous Peoples was the opening of the Center for Indigenous Cancer Research (CICR) at Roswell Park Comprehensive Cancer Center in January 2020. Its mission: to reduce the impact of cancer on Indigenous communities regionally, nationally, and internationally.
With the enormous pressures of COVID-19, the ever-increasing complexity of oncology care, and the persistent social factors that lead to medical injustice, it is difficult to think about tackling even one more job. Yet, we must, we can, and we do. Today I want to mention four specific areas that all cancer programs need to be watching, thinking about, and preparing for.
This is the story of how a large independent practice in northwest Arkansas has nurtured its research program over several decades and is now able to offer patients access to phase I, II, and III trials close to home and their families.
In this article, we describe patients’ perspectives on participation in CCDR studies based on feedback and comments received from patients during our research. Insights reveal the importance and enthusiasm for CCDR studies expressed by patients, and their perspectives on these studies will inform future research and clinical practice toward high quality, patient-centered care delivery.
With more than 25 years of oncology nursing experience and more than 18 years as an oncology nurse practitioner, Christa Braun-Inglis, MS, APRN-Rx, FNP-BC, AOCNP, has a wealth of clinical expertise.
Listed are my highlights of the ASCO 2020 abstracts, which were chosen if they were a practice-changing study or trial with important new advances.
Evidence-based diet and exercise interventions and programs that can improve cancer survivors’ quality of life and physical and mental health.
The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute’s Cancer and Aging Resilience (CARE) Clinic goes beyond reviewing cancer-specific treatment. This new care model pairs patients with a multidisciplinary team to assess patients for balance, cognition, nutrition, symptom management, and many more—all in one visit.
The amazing advances seen in cancer care are the result of successful completion of clinical trials. But the fact is that we could do so much better.
In Louisiana, cancer incidence and death rates are greater than the national average. However, access to early phase clinical trials was nearly impossible to find. 2018 ACCC Innovator Award winner Ochsner Health System partnered with the Translational Genomics Research institute to establish a dedicated center to that accelerated treatment development and expanded patient access to precision …
In the Department of Pharmacy at the University of North Carolina North Carolina Cancer Hospital, discarding partial drug vials was a significant source of waste. With their Innovator Award–winning drug vial optimization program, the program maximized the lifespan of drugs within single-dose vials and realized an annual cost savings of more than $40 million.
The ACCC Immuno-Oncology Institute developed a multidisciplinary curriculum workshop bringing together faculty experienced in delivery of immunotherapy with cancer program staff in the earlier stages of IO integration. Over the past two years, these IO Visiting Experts Programs were hosted by ACCC Cancer Program Members nation-wide.
CRISPR, a gene editing tool, has entered the scientific arena and public discourse at an astounding speed. Eric B. Kmiec, PhD, director of the Gene Editing Institute at the Helen F. Graham Cancer Center & Research Institute, discusses the emergence of gene editing, how it can be utilized as a tool in the battle against cancer, and the challenges facing its transition from bench to bedside.
Fertility preservation is an increasing concern for adolescent and young adult (AYA) patients with cancer. However, not all newly diagnosed males discuss fertility preservation with a healthcare provider before treatment. This quality improvement project describes the oncofertility program development that was part of a larger goal to develop an AYA oncology program at our institution, the University …
As the team of Northwest Medical Specialties discussed its approach to meeting OCM requirements, we realized that the program required rigor and processes like those found in clinical research programs, and an idea surfaced. Employing practices, procedures, and rules commonly used by those who work in a clinical research setting looked like a promising avenue for OCM implementation.
    Displaying results 1 - 20 of 24
  • 1
  • 2
  • »